Generated Narrative: ResearchStudy

ECLAIREReviewDate: Jan 6, 2023, 12:00:00 AM

ECLAIREApprovalDate: Mar 6, 2023, 12:00:00 AM

ECLAIRETherapeuticArea: domaine thérapeutique z

ECLAIRERecruitmentPeriod: 2022-06-30 00:00:00+0000 --> (ongoing)

ECLAIRERecruitmentStatus: Actif / active (Statut de recrutement#recruiting)

Extension Definition for ResearchStudy.descriptionSummary for Version 5.0: Ceci est un test de ressource pour Eclaire

ECLAIREoutcomeMeasureR5

url

value

value: Nom de la conséquence primaire

url

type

value: primaire (ResearchStudyObjectiveType#primary)

url

description

value: Description de la conséquence primaire

url

description

​value: EvidenceVariable/1: Aïe!

ECLAIREoutcomeMeasureR5

url

value

value: Nom de la conséquence secondaire

url

type

value: secondaire (ResearchStudyObjectiveType#secondary)

url

description

value: Description de la conséquence secondaire

url

description

​value: EvidenceVariable/1: Ouille!

ECLAIREassociatedPartyR5

url

name

value: THE sponsor

url

role

value: Sponsor principal (Définition des rôles des parties prenantes inspiré de http://hl7.org/fhir/research-study-party-role#lead-sponsor)

url

period

value: 2022-06-30 00:00:00+0000 --> (ongoing)

url

classifier

value: academic (Définition des différents types d'organisation des parties prenantes inspiré de http://hl7.org/fhir/research-study-party-organization-type#academic)

url

party

​value: Organization/2: Etablissement du sponsor

ECLAIRELabelR5

url

value

value: INDISPONIBLE

url

type

value: type (Définition des types de titre pour l'essai#human-use)

ECLAIRELabelR5

url

value

value: INDISPONIBLE

url

type

value: type (Définition des types de titre pour l'essai#acronym)

identifier: Hilarious Cat/123456 (use: OFFICIAL), 2022-500014-26-00 (use: SECONDARY)

title: Energetic Zebra

​protocol: PlanDefinition/3: Energetic plan

status: in-review

primaryPurposeType: Zebra treatment (ResearchStudyPrimaryPurposeType[4.0.1]#treatment)

phase: Research Study Phase (ResearchStudyPhase#phase-3)

category: IC-Cas 1 (DM) (Précision sur la réglementation concernant l'essai#IC-Cas-1)

focus: Hilarious medicament ()

condition: Locally-Advanced or Metastatic breast cancer (MBC) (), MedDRA condition code 10070575 (mdr#10070575 "10070575")

contact: Slow Zebra: ph: Energetic Zebra(WORK),ph: Energetic Badger(HOME)

keyword: Fast Elephant ()

location: Countries of recruitment (ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code[4.0.1]#FR)

description: This is a fake research study

​enrollment: Group/6: Fast Zebra

​site: Location/8: Rainbow

reasonStopped: ouch (ResearchStudyReasonStopped[4.0.1]#closed-due-to-toxicity)

Arms

Objectives